Sponsors & exhibitors
Commercial opportunities
Download Salespack(opens in new tab/window)
Choose from a variety of sponsorship and commercial options to raise your profile and position your company as a thought leader in the community.
Reasons why being a sponsor is a brilliant marketing strategy
Highly targeted marketing – reach your community
Brand awareness & recognition – logo and advertisement placement
Access to knowledge – find out about new research being undertaken
Engage with your audience – at the event and online
Media exposure - benefit from being promoted throughout Elsevier’s marketing process
Enhance credibility – highlight your company’s expertise to a captive audience
Generate new sales & form new partnerships – with registrants, vendors and speakers
Leveraged lead generation - the chance to be recommended to attendees’ connections
An exhibition will run alongside the conference sessions. Space is available on a first-come, first-served basis. In addition, a range of commercial sponsorship opportunities are available.
To discuss your requirements or to book sponsorship or exhibit space please contact:
Chloe Partridge Sales Manager STMJ Conferences | Elsevier The Boulevard | Langford Lane | Kidlington | Oxford | OX5 1GB Email : [email protected] (opens in new tab/window)(Please do not email credit card information under any circumstances) T: +44 1865 84 3846 | F: +44 1865 84 3973 | M: +44 0777 184 0678
Sponsor
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines in Oncology and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
Exhibitors
Oxeltis is a medicinal chemistry services company created in 2010 in Montpellier, France, by former researchers from Idenix Pharmaceuticals (formerly MSD). The company has a small-scale custom synthesis business and hit and lead optimization services in various areas, such as antivirals, antibiotics, and anticancer compounds. Oxeltis’ scientific team comprises experienced chemists with recognized expertise in specific areas of organic synthesis: heterocycles, macrocycles, nucleosides/nucleotides, phosphoramidites, modified sugars, oligo/polysaccharides, short peptides, linkers and PROTACs. The team is focused on speed of delivery, quality, and confidentiality of the services and collaborations it develops. Oxeltis has completed more than 40 projects with complex synthetic chemistry for pharmaceutical and biotechnology companies, including five of the ten largest global pharmaceutical companies. Several drug candidates delivered to its customers are in clinical development. Oxeltis works with European, Japanese, and North American start-ups, big pharma companies, and research institutions.
More information coming soon
